The success of insitro relies at its core on our ability to attract, retain, and develop talented individuals across a spectrum of high-demand disciplines, and to foster a high-performance culture that synthesizes those disciplines into a whole which is greater than the sum of its parts.
The Recruiting Coordinator will be a key member of the People and Culture team to support our recruitment efforts with the objective to help us build exceptional teams and significantly grow our organization by successfully coordinating high-volume, fast-paced talent acquisition and recruiting activities.
As the first contact for candidates you’ll be instrumental in creating an awesome candidate experience. You will help grow the company by ensuring seamless logistics and timely planning with candidate interviews for many different functional roles, as well as recruiting-related (virtual) events and meetings. If you thrive on being resourceful, well organized and eager to grow your career in recruiting and people operations, we predict that you’ll enjoy this role!
You will be joining a thriving and growing biotech startup that has long-term stability due to significant funding, yet is very much in formation and providing many opportunities for significant impact. You will work closely with collaborative hiring managers, a very talented team, learn a broad range of skills, and help shape insitro’s culture for its next stage of growth. Join us, and help make a difference to patients!
Primarily, in this role you will:
Benefits at insitro
insitro is a data-driven drug discovery and development company using machine learning and high-throughput biology to transform the way that drugs are discovered and delivered to patients. The company is applying state-of-the-art technologies from bioengineering to create massive data sets that enable the power of modern machine learning methods to be brought to bear on key bottlenecks in pharmaceutical R&D. The resulting predictive models are used to accelerate target selection, to design and develop effective therapeutics, and to inform clinical strategy. insitro was launched in 2018 with a Series A of $100M funded by top investors including a16z, Arch Venture Partners, Foresite Capital, GV, and Third Rock Ventures. In 2019 the company announced a collaboration with Gilead Sciences in the area of NASH, a collaboration with BMS in the area of ALS, and in mid 2020, announced a Series B financing of $143M including current investors and new investors Canada Pension Plan Investment Board (CPP Investments), T. Rowe Price, BlackRock, Casdin Capital and other leading investors. The company is located in South San Francisco, CA. For more information about insitro, please visit the company’s website at www.insitro.com
Your application was submitted successfully.